Immune Efficacy of a Genetically Engineered Vaccine against Lymphocystis Disease Virus: Analysis of Different Immunization Strategies

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="1"><hr/></td></tr><tr><td align="left">ATGATCGGTAATACTATTGATATGACACAACCCGTTGATTCCAATGGTCAATT</td></tr><tr><td align="left">ACCTGAAGAAGTGTTAATACTTCCTTTACCTTATTTCTTTTCTCGAGATAGCG</td></tr><tr><td align="left">GTATGGCTTTACCCAGCGCTGCTTTGCCTTATAATGAAATAAGATTAACTTTT</td></tr><tr><td align="left">CATCTGAGAGATTGGACTGAATTATTGATCTTTCAAAATAAAAACGACTCTA</td></tr><tr><td align="left">CCATCATGCCTTTGACAGCAGGCGATTTAGACTGGGGTAAACCTGATTTAA</td></tr><tr><td align="left">AGGATGTGCAAGTATGGATTACTAATGTAGTAGTAACCAATGAGGAACGTC</td></tr><tr><td align="left">GTTTAATGGGTACAGTACCTAGAGACATCTTGGTGGAACAGGTACAAACAG</td></tr><tr><td align="left">CACCTAAACATGTATTTCAACCTCTAACTATTCCAAGTCCTAATTTTGACATC</td></tr><tr><td align="left">AGATTTTCTCATGCCATTAAAATCCTTTTTTTCGGTGTGCGTAATGTTACCTA</td></tr><tr><td align="left">TCAAGCTATACAATCCAATTACACCAGTTCTTCTCCTGTAATCTTTGACGGT</td></tr><tr><td align="left">GGAATTGCTAGCGATTTACCGGGTATTGCTGCTGATCCTATTTCAAATGTTAC</td></tr><tr><td align="left">CTTGGTTTATGAAAATAGTGCTCGTCTTAATGAAATGGGTAGTGAATAT</td></tr><tr class="table-tr"><td colspan="1"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

The 0.6 kb MCP sequence of ORF0147 (71318–71696 amino acids).

Evidence-Based Complementary and Alternative Medicine

tab1

Table 1

Table 1: Immune Efficacy of a Genetically Engineered Vaccine against Lymphocystis Disease Virus: Analysis of Different Immunization Strategies 